An Open-Label, 2-Period, Crossover Study to Evaluate the Effects of Multiple Doses of JNJ-28431754 on the Pharmacokinetics of Multiple Doses of Digoxin in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 27 Oct 2014
At a glance
- Drugs Canagliflozin (Primary) ; Digoxin (Primary)
- Indications Arrhythmias; Obesity; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 16 Nov 2012 New trial record